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Background: Observational epidemiologic data suggest
that transmission of viral respiratory infection was signif-
icantly reduced during the SARS epidemic with the use of
face masks as well as other infection control measures. How-
ever, there are no prospective randomised control trials on
face masks in prevention of viral respiratory infections Aims:
To determine the efﬁcacy of surgical masks and P2 masks in
households on the interruption of transmission of respiratory
viruses.
Methods: Prospective cluster randomized trial comparing
surgical masks, non-ﬁt-tested P2 (respirator) masks with no
masks in interruption of viral transmission between house-
hold members. Families of children presenting to emergency
department with inﬂuenza like illness (ILI) were randomised
to one of the three groups and followed up for devel-
opment of respiratory illness in other family members.
Nasopharyngeal swabs of index patients and contacts that
developed ILI were tested with a multiplex respiratory viral
PCR for inﬂuenza A and B, parainﬂuenza, RSV, picornavirus,
enterovirus, rhinovirus, adenovirus, coronaviruses human
metapneumovirus.
Results: We recruited 286 adults with exposure to respi-
ratory infections in the Australian winters of 2006 and 2007 -
94 adults were randomized to surgical masks, 90 to P2 masks
and 102 to the control group. Using intention to treat analy-
sis, we found no signiﬁcant difference in the relative risk of
respiratory illness in the mask groups compared to control
group. However, compliance with mask use was less than
50%. In an adjusted analysis of compliant subjects, masks as
a group had protective efﬁcacy in excess of 80% against clin-
ical inﬂuenza-like illness. The efﬁcacy against proven viral
infection and between P2 masks (57%) and surgical masks
(33%) was non-signiﬁcant.
Conclusions: This is the ﬁrst RCT on mask use to be con-
ducted and provides data to inform pandemic planning. We
found compliance to be low, but compliance is affected by
perception of risk. In a pandemic, we would expect com-
pliance to improve. In compliant users, masks were highly
efﬁcacious. A larger study is required to enumerate the dif-
ference in efﬁcacy (if any) between surgical and non-ﬁt
tested P2 masks.
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Introduction: Since February/March 2005, Chikungunya
has been an emerging infection in the Indian Ocean. We
report an observational study to describe the complications
post-Chikungunya in a sample of affected people in Mauri-
tius.
Methods: Ethical clearance was obtained for this study.
Data collection was carried out in February and March 2007
on a random sample of people who had suffered from
Chikungunya in 2005 and 2006. Data was collected by means
of a comprehensive questionnaire.
Results: Participants comprised 77 people of whom 41
were males and 36 were females. Participants ranged from
6 to 69 years. It was found that 70 of the participants expe-
rienced persisting joint pains for at least 6 months following
the acute phase. 35 of these participants had residual joint
complaints after 6 months. 44 of all participants suffered
from psychological sequelae out of which 37 complained of
pessimism, 35 of lack of concentration, 31 of insomnia, 31
of depression, 22 of aggressiveness, and 17 of confusion. 10
participants had dermatological sequelae which consisted of
increased pigmentation on the face or on limb extremities,
6 had iatrogenic complications due to NSAIDS induced gastri-
tis, and 3 participants with serologically proven Chikungunya
had neurological manifestations and changes on CT/MRI
which could correspond to demyelination. Complications
increased with age. From July 2005 till June 2006, there
was a signiﬁcant increase in the number of deaths which
could be Chikungunya related. Statistical analysis demon-
strated that there was a signiﬁcant difference in the number
of complications according to gender, females being more
affected than males and also in those participants with co-
morbidity being more affected than others. Psychological
sequelae were found to be dependent on co-morbidity.
Discussion and conclusion: Though this study had lim-
itations such as a small sample size and the data relied
mostly on clinical diagnosis, results yield useful information
on complications of Chikungunya. This study highlights that
Chikungunya which causes a signiﬁcant impact on health in
the acute phase can have signiﬁcant sequelae months after-
wards and this includes psychological sequelae. More studies
need to be carried out to conﬁrm these preliminary ﬁndings.
doi:10.1016/j.ijid.2008.05.878
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Background: Dengue virus (DEN-V) infection has become
one of the major public health problems in many tropical
